Results 111 to 120 of about 119,738 (212)
Biosimilars in pemphigus vulgaris
Sharmila Patil +3 more
openaire +3 more sources
Successful treatment of rituximab-refractory pemphigus vulgaris with Obinutuzumab. [PDF]
Saraç MT +5 more
europepmc +1 more source
Pemphigus vulgaris-a blistering clinical enigma: case report. [PDF]
Ganesan A +3 more
europepmc +1 more source
The transition of pemphigus vulgaris into pemphigus foliaceus: A case report. [PDF]
Stasiewicz A +4 more
europepmc +1 more source
Gold and Pemphigus vulgaris [PDF]
S, Kielwasser, E, Heid, E, Grosshans
openaire +2 more sources
The discovery of the role of Bruton's Tyrosine Kinase (BTK) in inflammation and autoimmunity has recently led to the development of BTK inhibitors for the treatment of autoimmune diseases, including pemphigus vulgaris.
Ciolfi C +5 more
core +1 more source
Colonic Ischemia in a Patient With Pemphigus Vulgaris: Coincidence or Causation. [PDF]
Joshi R +6 more
europepmc +1 more source
Systemic and Oral Manifestation of Pemphigus vulgaris(Case Report)
Pemphigus vulgaris is a serious autoimmune disease that forms blisters on mucosa and skin. It is common in people over 60 years of age, and it has a strong genetic tendency, Autoantibodies can be found in intercelluar spaces between epithelial cells, and
최종훈 +3 more
core
Drug-Induced Pemphigus Vulgaris Following Ceftriaxone Use. [PDF]
Amadi A +4 more
europepmc +1 more source
Critical analysis of pemphigus vulgaris in pregnancy. [PDF]
Shah T, Baltabaev A, Geng Y, Ahmed AR.
europepmc +1 more source

